Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Maternal-Fetal Medicine

What Is the Recurrence Risk of Placental Insufficiency?

At a Glance

Placental insufficiency may recur, but recurrence is not inevitable. Poor fetal growth recurs in about 20%–30% of cases; preeclampsia recurs in about 10%–16% overall and more often after early-onset disease. Specialist planning can guide monitoring.

If you experienced a complicated pregnancy due to a placental issue, it is completely normal to wonder if it will happen again. The direct answer is that while having a history of placental complications increases your risk in future pregnancies, it is absolutely not a guarantee that it will recur. Many people go on to have healthy subsequent pregnancies. Your specific risk depends heavily on your exact prior diagnosis, how early in the pregnancy it occurred, and whether you have underlying health conditions [1][2].

Understanding the Terminology
“Placental insufficiency” is an umbrella term rather than a single diagnosis. It broadly describes a placenta that struggles to deliver enough oxygen and nutrients to the baby [3]. This can result in several different conditions. For instance, it can cause Fetal Growth Restriction (FGR), where a baby is not growing as expected due to the placenta. This is different from a baby who is Small for Gestational Age (SGA) simply because their parents are small; an SGA baby may be constitutionally small but perfectly healthy without placental involvement [3]. Placental issues can also manifest as preeclampsia or placental abruption.

Recurrence Statistics Based on Your History

Recurrence percentages are population estimates, not absolute individual predictions. Your personal risk may be higher or lower based on your unique health profile.

Prior Pregnancy Condition Estimated Recurrence Risk Key Details
Fetal Growth Restriction (FGR) 20% to 30% The risk increases if you have had more than one prior pregnancy affected by FGR [2][4].
Preeclampsia (Overall) 10% to 16% This is the general risk for anyone with a history of preeclampsia [1][5].
Early-Onset Preeclampsia 20% to 33% If your previous preeclampsia required delivery before 34 weeks, your risk of developing any preeclampsia again is higher [6][7]. While a recurrence often happens later in pregnancy and is less severe, an early or severe recurrence is still possible [5].
Placental Abruption 3% to 6% Placental abruption is when the placenta separates from the uterine wall early. The baseline recurrence risk is around 3% to 6% [8][9].

Rare Placental Pathology
If your placenta was examined in a lab after birth (placental pathology), it might show specific, rare conditions like massive perivillous fibrinoid deposition (a heavy build-up of protein that blocks nutrient transfer) or chronic histiocytic intervillositis (an inflammatory condition of the placenta) [10]. Small studies suggest these specific lesions may have a recurrence risk of 50% or higher, though estimates vary widely [10]. Knowing your exact pathology is crucial for future planning.

Pre-Conception Planning

The best time to plan for a future pregnancy is before you conceive. Meeting with a maternal-fetal medicine (MFM) specialist can help you build an individualized plan.

  • Gather Your Records: Before your visit, collect your past ultrasound reports, delivery records, and most importantly, the complete placental pathology report [10].
  • Optimize Chronic Conditions: If you have chronic hypertension, diabetes (type 1 or type 2), kidney disease, or an autoimmune condition, working with your doctors to manage these can improve your outcomes [11][12].
  • Medication Review: Do not stop taking blood pressure medications, insulin, or autoimmune therapies on your own. Your doctor will help you safely transition to pregnancy-compatible options [11].
  • Autoimmune Specifics: Conditions like lupus and Antiphospholipid Syndrome (APS) require careful planning. For example, patients with APS may need a specialized regimen involving both low-dose aspirin and a blood thinner (like low-molecular-weight heparin) to support a future pregnancy, as aspirin alone may not be enough [13][11].

Low-Dose Aspirin

Taking low-dose aspirin (81 mg) daily is an evidence-based strategy that can reduce the risk of preeclampsia and FGR in certain high-risk patients, though it does not guarantee prevention [14][15].

The American College of Obstetricians and Gynecologists (ACOG) does not recommend aspirin for every type of prior placental issue. Instead, ACOG recommends it for patients who meet specific high-risk criteria—such as a history of preeclampsia, chronic hypertension, diabetes, or autoimmune disease—or those with multiple moderate-risk factors [16].

  • Timing: If recommended, it is optimally started between 12 and 16 weeks of pregnancy, and typically continued until delivery [16].
  • Cautions: You should only start aspirin after your clinician reviews your history for allergies, bleeding disorders, or aspirin-sensitive asthma [16].

Individualized Monitoring and Safety

In a future pregnancy, your care team will likely recommend a tailored monitoring schedule to watch for complications early. Monitoring cannot prevent placental insufficiency, but it allows your team to intervene promptly if the placenta begins to struggle [17].

Depending on your history, your schedule may include:

  • Serial Growth Ultrasounds: Regular ultrasounds in the third trimester to track the baby’s size [17].
  • Doppler Ultrasounds: Scans that measure blood flow. An umbilical artery Doppler is commonly used if FGR is suspected, to see how well the placenta is functioning [17][18]. Uterine artery Dopplers may also be used in some cases, though they are not routine for everyone.
  • Maternal Checks: Frequent blood pressure checks and urine protein tests to watch for signs of preeclampsia [18].

Your Safety Net: When to Call the Doctor
Because you are at a higher risk for preeclampsia and placental issues, you should have a low threshold for contacting your maternity team. Seek urgent medical advice if you experience:

  • Severe or persistent headaches
  • Changes in your vision (seeing spots or flashing lights)
  • Pain in your upper right abdomen
  • Shortness of breath
  • Any vaginal bleeding or severe abdominal pain
  • A noticeable decrease in your baby’s movements [19]

Remember that anxiety is very common during a pregnancy after a complication. Seeking support from a perinatal mental health counselor or a pregnancy-after-loss group is a valid and important part of your care plan.

Common questions in this guide

Can placental insufficiency happen again in a later pregnancy?
Yes, a previous placental complication raises the chance of another complication, but recurrence is not certain. The risk depends on whether the earlier problem was fetal growth restriction, preeclampsia, placental abruption, or a rare placental lesion, as well as how early it occurred and your health conditions.
What is the chance of fetal growth restriction happening again?
After fetal growth restriction, recurrence is estimated at about 20% to 30%, and the risk may be higher after more than one affected pregnancy. This is a population estimate, so a maternal-fetal medicine specialist should interpret it with your records and health history.
How likely is preeclampsia after having it in a previous pregnancy?
After any preeclampsia, the estimated recurrence risk is about 10% to 16%. If the prior condition required delivery before 34 weeks, the risk of preeclampsia in a later pregnancy is about 20% to 33%; it often occurs later and is less severe, but serious recurrence can still happen.
Can low-dose aspirin prevent placental insufficiency from returning?
Low-dose aspirin may reduce preeclampsia and fetal growth restriction in some high-risk pregnancies, but it does not guarantee prevention and is not recommended for every prior placental problem. If your clinician recommends it, it is usually started at 12 to 16 weeks and continued until delivery after checking for allergies, bleeding risk, or aspirin-sensitive asthma.
What should I do before trying to conceive after a placental complication?
Before trying to conceive, meet with maternal-fetal medicine to review your delivery records and complete placental pathology report, optimize conditions such as hypertension, diabetes, kidney disease, or autoimmune disease, and review medications. Do not stop blood pressure, insulin, or autoimmune medicines without medical guidance.
What monitoring might I need in a future pregnancy?
Monitoring in a future pregnancy may include serial growth ultrasounds, blood pressure and urine checks, and Doppler ultrasound to assess blood flow when indicated. The schedule is individualized and helps the care team detect problems early; it cannot prevent placental insufficiency by itself.
Which symptoms require urgent medical attention in a future pregnancy?
Seek urgent medical advice for a severe or persistent headache, vision changes, upper-right abdominal pain, shortness of breath, vaginal bleeding, severe abdominal pain, or noticeably fewer fetal movements. These symptoms can signal a pregnancy complication and should not wait for a routine appointment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we review the pathology report from my previous placenta to see if it shows a specific condition that alters my recurrence risk?
  2. 2.Based on my specific diagnosis and health history, what is my individual estimated recurrence risk?
  3. 3.Am I a candidate for low-dose aspirin in my next pregnancy, and if so, when should I start taking it?
  4. 4.What specific medications do I need to adjust or switch before I start trying to conceive?
  5. 5.What will my personalized monitoring schedule (e.g., third-trimester growth scans or Dopplers) look like in a future pregnancy?
  6. 6.At what blood pressure reading, or for what specific symptoms, should I contact the office or go to triage?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Pre-eclampsia in a first pregnancy and subsequent pregnancy outcomes: a nationwide cohort study.

    Havers-Borgersen E, Fosbøl E, Johansen M, et al.

    Journal of epidemiology and community health 2023; (77(11)):694-703 doi:10.1136/jech-2023-220829.

    PMID: 37541773
  2. 2

    Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies.

    Blue NR, Page JM, Silver RM

    Obstetrics and gynecology clinics of North America 2021; (48(2)):419-436 doi:10.1016/j.ogc.2021.03.002.

    PMID: 33972075
  3. 3

    An integrated approach to fetal growth restriction.

    Figueras F, Gratacos E

    Best practice & research. Clinical obstetrics & gynaecology 2017; (38()):48-58 doi:10.1016/j.bpobgyn.2016.10.006.

    PMID: 27940123
  4. 4

    The risk of recurrent small-for-gestational-age infants at term is dependent on the number of previously affected births.

    Bhamidipaty-Pelosi S, Fox J, Greer RM, Kumar S

    American journal of obstetrics and gynecology 2021; (225(4)):415.e1-415.e9 doi:10.1016/j.ajog.2021.04.219.

    PMID: 33848539
  5. 5

    Recurrence risk of preeclampsia in a linked population-based cohort: Effects of first pregnancy maximum diastolic blood pressure and gestational age.

    Bernardes TP, Mol BW, Ravelli ACJ, et al.

    Pregnancy hypertension 2019; (15()):32-36 doi:10.1016/j.preghy.2018.10.010.

    PMID: 30825924
  6. 6

    Early-onset preeclampsia appears to discourage subsequent pregnancy but the risks may be overestimated.

    Seeho SK, Algert CS, Roberts CL, Ford JB

    American journal of obstetrics and gynecology 2016; (215(6)):785.e1-785.e8 doi:10.1016/j.ajog.2016.07.038.

    PMID: 27457117
  7. 7

    Preeclampsia before 26 weeks of gestation: Obstetrical prognosis for the subsequent pregnancy.

    Gottardi E, Lecarpentier E, Villette C, et al.

    Journal of gynecology obstetrics and human reproduction 2021; (50(3)):102000 doi:10.1016/j.jogoh.2020.102000.

    PMID: 33221560
  8. 8

    Incidence and recurrence rate of placental abruption: a longitudinal linked national cohort study in the Netherlands.

    Ruiter L, Ravelli AC, de Graaf IM, et al.

    American journal of obstetrics and gynecology 2015; (213(4)):573.e1-8.

    PMID: 26071916
  9. 9

    Placental abruption: Incidence and risk of recurrence in subsequent pregnancies.

    Oyelese Y, Peltier M, Donovan B, et al.

    The journal of obstetrics and gynaecology research 2024; (50(5)):821-827 doi:10.1111/jog.15906.

    PMID: 38366767
  10. 10

    A placenta clinic approach to the diagnosis and management of fetal growth restriction.

    Kingdom JC, Audette MC, Hobson SR, et al.

    American journal of obstetrics and gynecology 2018; (218(2S)):S803-S817 doi:10.1016/j.ajog.2017.11.575.

    PMID: 29254754
  11. 11

    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

    Andreoli L, Bertsias GK, Agmon-Levin N, et al.

    Annals of the rheumatic diseases 2017; (76(3)):476-485 doi:10.1136/annrheumdis-2016-209770.

    PMID: 27457513
  12. 12

    Systemic lupus erythematosus and pregnancy: a comprehensive clinical review of maternal, fetal, and treatment considerations.

    Wyszynski DF

    Advances in rheumatology (London, England) 2026; (66(1)).

    PMID: 42271552
  13. 13

    Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.

    Saccone G, Berghella V, Maruotti GM, et al.

    American journal of obstetrics and gynecology 2017; (216(5)):525.e1-525.e12 doi:10.1016/j.ajog.2017.01.026.

    PMID: 28153662
  14. 14

    The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.

    Roberge S, Nicolaides K, Demers S, et al.

    American journal of obstetrics and gynecology 2017; (216(2)):110-120.e6 doi:10.1016/j.ajog.2016.09.076.

    PMID: 27640943
  15. 15

    Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?

    Chaemsaithong P, Cuenca-Gomez D, Plana MN, et al.

    American journal of obstetrics and gynecology 2020; (222(5)):437-450 doi:10.1016/j.ajog.2019.08.047.

    PMID: 31494125
  16. 16

    ACOG Committee Opinion No. 743 Summary: Low-Dose Aspirin Use During Pregnancy.

    Obstetrics and gynecology 2018; (132(1)):254-256 doi:10.1097/AOG.0000000000002709.

    PMID: 29939936
  17. 17

    Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.

    McCowan LM, Figueras F, Anderson NH

    American journal of obstetrics and gynecology 2018; (218(2S)):S855-S868 doi:10.1016/j.ajog.2017.12.004.

    PMID: 29422214
  18. 18

    Clinical Assessment of Fetal Well-Being and Fetal Safety Indicators.

    David AL, Spencer RN

    Journal of clinical pharmacology 2022; (62 Suppl 1()):S67-S78 doi:10.1002/jcph.2126.

    PMID: 36106777
  19. 19

    Stillbirths preceded by reduced fetal movements are more frequently associated with placental insufficiency: a retrospective cohort study.

    Ter Kuile M, Erwich JJHM, Heazell AEP

    Journal of perinatal medicine 2022; (50(6)):668-677 doi:10.1515/jpm-2021-0103.

    PMID: 34261204

This page provides general information about recurrence after placental insufficiency and does not constitute medical advice. A maternal-fetal medicine specialist should review your prior diagnosis, pathology, health conditions, and medications to create an individualized plan.

Get notified when new evidence is published on Placental insufficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.